Stanny Geerts

Stanny Geerts

Auto-generated profile, based on publicly available information

Stanny Geerts

Institute of Tropical Medicine, Antwerp, Belgium

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1992 in Veterinary Parasitology
Verified
Journal Article
Closed access
GCG.C. Coles
G.C. Coles
CBChristian Bauer
Christian Bauer
FBF.H.M. Borgsteede
F.H.M. Borgsteede
SGS. Geerts
S. Geerts
TKT.R. Klei
T.R. Klei
PWP.J. Waller
P.J. Waller

1 April 2000 in Clinical Microbiology Reviews
Verified
Journal Article
Open access
PDF file
SGS. Geerts
S. Geerts
BGB. Gryseels
B. Gryseels
In this review the available reports on drug resistance in human helminths, particularly hookworms and schistosomes, are critically analyzed. The experiences with helminths of livestock are then reviewed, in particular the factors contributing to the development of anthelmintic resistance, the mechanisms and genetics of resistance to various anthelmintic classes, and the methods available for detection. These experiences appear to be worryingly similar and relevant to the potential development of drug resistance in human helminths. Recommendations to reduce its risks are suggested.

1 January 2001 in Trends in Parasitology
Verified
Journal Article
Closed access
SGStanny Geerts
Stanny Geerts
PHPeter H Holmes
Peter H Holmes
Mark EislerMark Eisler
Mark Eisler
ODOumar Diall
Oumar Diall

1 July 1992 in International Journal for Parasitology
Verified
Journal Article
Closed access
JBJ.R.A. Brandt
J.R.A. Brandt
SGS. Geerts
S. Geerts
RDR.DE Deken
R.DE Deken
VKV. Kumar
V. Kumar
FCF. Ceulemans
F. Ceulemans
NFN. Falla
N. Falla

1 February 2000 in Veterinary Parasitology
Verified
Journal Article
Closed access
PDPierre Dorny
Pierre Dorny
FVF Vercammen
F Vercammen
JBJ Brandt
J Brandt
WVW Vansteenkiste
W Vansteenkiste
DBD Berkvens
D Berkvens
SGS Geerts
S Geerts

1 September 2004 in Infection and Immunity
Verified
Journal Article
Closed access
AFAna Flisser
Ana Flisser
CGCharles Gauci
Charles Gauci
AZAndré Zoli
André Zoli
JMJoel Martinez-Ocaña
Joel Martinez-Ocaña
AGAdriana Garza-Rodriguez
Adriana Garza-Rodriguez
MLMarshall Lightowlers
Marshall Lightowlers
Two recombinant Taenia solium oncosphere antigens, designated TSOL18 and TSOL45-1A, were investigated as vaccines to prevent transmission of the zoonotic disease cysticercosis through pigs. Both antigens were effective in inducing very high levels of protection (up to 100%) in three independent vaccine trials in pigs against experimental challenge infection with T. solium eggs, which were undertaken in Mexico and Cameroon. This is the highest level of protection that has been achieved against T. solium infection in pigs by vaccination with a defined antigen. TSOL18 and TSOL45-1A provide the basis for development of a highly effective practical vaccine that could assist in the control and, potentially, the eradication of human neurocysticercosis.